Corporate America is racing to capitalize on the GLP-1 weight loss drug boom, reshaping retail shelves and consumer behavior in ways that signal a massive market shift ahead.
Quick Take
- Target and major retailers are aggressively expanding protein and supplement sections to meet surging demand from GLP-1 users.
- The weight loss medication market could reach $150 billion by 2035, with U.S. patients potentially rising from 8 million to 30 million
- Companies like Nestlé, Conagra, and Danone are launching GLP-1-specific product lines to capture growing consumer spending
- Retailers are also seeing increased demand for athletic wear and home fitness equipment as users adopt more active lifestyles
Retailers Recognize the GLP-1 Opportunity
Target is leading the charge to meet the nutritional demands of GLP-1 users. Lisa Roath, Target’s chief merchandising officer for food, essentials, and beauty, told FOX Business that the company is “at the tip of the iceberg” in terms of how these medications will reshape consumer behavior.
Target plans to expand shelf space in early 2026 specifically for protein items, nutrition bars, and supplements. This strategic pivot reflects the company’s recognition that GLP-1 users face unique nutritional challenges due to the medications’ appetite suppression.
Target beefs up protein, supplement offerings, capitalizing on weight loss drug trend https://t.co/zCp4zpVZKy
— FOX Business (@FoxBusiness) December 10, 2025
The Massive Market Opportunity
The numbers tell a compelling story about where this market is headed. Currently, approximately 8 million Americans use GLP-1 medications, but Morgan Stanley projects that figure could skyrocket to 30 million by 2035—representing 20 to 25 percent of the obese population.
The weight-loss medication market could reach $150 billion by 2035, creating an $80 billion opportunity in the U.S. alone. These projections explain why major corporations are aggressively repositioning their product portfolios to capture this expanding consumer segment.
Corporate Giants Launch GLP-1-Specific Products
Beyond Target, established brands are directly targeting GLP-1 users with specialized products. Nestlé Health Science launched a platform offering “holistic and personalized care” with tailored products addressing muscle preservation, digestive health, and micronutrient intake.
Conagra Brands introduced “on track” badges for products that are high in protein, low in calories, and rich in fiber. Danone North America launched Oikos Fusion yogurt, designed explicitly for GLP-1 users, positioning it as the first yogurt to address the unique nutritional challenges these consumers face on weight-loss journeys.
Beyond Food: The Broader Lifestyle Shift
The GLP-1 phenomenon extends far beyond grocery aisles. As users experience weight changes and adopt more active lifestyles, retailers are witnessing increased demand for athletic wear and home fitness equipment.
Target reports already seeing growth in these categories, with customers investing in weights and fitness gear alongside their nutritional upgrades. This broader lifestyle transformation demonstrates how pharmaceutical innovation is reshaping multiple retail sectors simultaneously, creating opportunities across health, wellness, and fitness industries.
